+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Critical Care Therapeutics Market 2021-2025- Product Image

Global Critical Care Therapeutics Market 2021-2025

  • ID: 5238538
  • Report
  • January 2021
  • Region: Global
  • 120 pages
  • TechNavio

FEATURED COMPANIES

  • Baxter International Inc.
  • Bristol-Myers Squibb Co.
  • CSL Ltd.
  • Grifols SA
  • Kedrion Spa
  • LFB SA
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Global Critical Care Therapeutics Market 2021-2025

The publisher has been monitoring the critical care therapeutics market and it is poised to grow by $ 888.68 mn during 2021-2025 progressing at a CAGR of 5% during the forecast period. The report on critical care therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the high demand for albumin in China and increasing surgical procedures. In addition, high demand for albumin in China is anticipated to boost the growth of the market as well.

The critical care therapeutics market analysis includes drug class segment and geographical landscapes.

The critical care therapeutics market is segmented as below:

By Drug Class
  • Albumin
  • Antithrombin
  • Prothrombin complex
  • Factor XIII
  • Fibrinogen
By Geographical Landscapes
  • North America
  • Europe
  • Asia
  • ROW
This study identifies growing preference for marketed products over alternative treatment options as one of the prime reasons driving the critical care therapeutics market growth during the next few years.

The report on critical care therapeutics market covers the following areas:
  • Critical care therapeutics market sizing
  • Critical care therapeutics market forecast
  • Critical care therapeutics market industry analysis
The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading critical care therapeutics market vendors that include Baxter International Inc., Bristol-Myers Squibb Co., CSL Ltd., Grifols SA, Kedrion Spa, LFB SA, Novartis AG, Octapharma AG, Pfizer Inc., and Takeda Pharmaceutical Co. Ltd.. Also, the critical care therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Baxter International Inc.
  • Bristol-Myers Squibb Co.
  • CSL Ltd.
  • Grifols SA
  • Kedrion Spa
  • LFB SA
Executive Summary
  • Market Overview
Market Landscape
  • Market ecosystem
  • Value chain analysis
Market Sizing
  • Market definition
  • Market segment analysis
  • Market size 2020
  • Market outlook: Forecast for 2020 - 2025
Five Forces Analysis
  • Fiver forces analysis
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
Market Segmentation by drug class
  • Market segments
  • Comparison by Drug class
  • Albumin - Market size and forecast 2020-2025
  • Antithrombin concentrates - Market size and forecast 2020-2025
  • Prothrombin complex concentrates - Market size and forecast 2020-2025
  • Factor XIII concentrates - Market size and forecast 2020-2025
  • Fibrinogen concentrates - Market size and forecast 2020-2025
  • Market opportunity by Drug class
Customer landscape

Geographic Landscape
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2020-2025
  • Europe - Market size and forecast 2020-2025
  • Asia - Market size and forecast 2020-2025
  • ROW - Market size and forecast 2020-2025
  • Key leading countries
  • Market opportunity by geography
  • Market drivers
  • Market challenges
  • Market trends
Vendor Landscape
  • Vendor landscape
  • Landscape disruption
  • Industry risks
  • Competitive scenario
Vendor Analysis
  • Vendors covered
  • Market positioning of vendors
  • Baxter International Inc.
  • Bristol-Myers Squibb Co.
  • CSL Ltd.
  • Grifols SA
  • Kedrion Spa
  • LFB SA
  • Novartis AG
  • Octapharma AG
  • Pfizer Inc.
  • Takeda Pharmaceutical Co. Ltd.
Appendix
  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations
Exhibit
  • Key Finding 1
  • Key Finding 2
  • Key Finding 3
  • Key Finding 5
  • Key Finding 6
  • Key Finding 7
  • Key Finding 8
  • Parent market
  • Market characteristics
  • Offerings of vendors included in the market definition
  • Market segments
  • Global - Market size and forecast 2020 - 2025 ($ million)
  • Global market: Year-over-year growth 2020 - 2025 (%)
  • Five forces analysis 2020 & 2025
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition - Five forces 2020
  • Other1 - Market share 2020-2025 (%)
  • Comparison by Other1
  • Albumin - Market size and forecast 2020-2025 ($ million)
  • Albumin - Year-over-year growth 2020-2025 (%)
  • Antithrombin concentrates - Market size and forecast 2020-2025 ($ million)
  • Antithrombin concentrates - Year-over-year growth 2020-2025 (%)
  • Prothrombin complex concentrates - Market size and forecast 2020-2025 ($ million)
  • Prothrombin complex concentrates - Year-over-year growth 2020-2025 (%)
  • Factor XIII concentrates - Market size and forecast 2020-2025 ($ million)
  • Factor XIII concentrates - Year-over-year growth 2020-2025 (%)
  • Fibrinogen concentrates - Market size and forecast 2020-2025 ($ million)
  • Fibrinogen concentrates - Year-over-year growth 2020-2025 (%)
  • Market opportunity by Other1
  • Customer landscape
  • Market share by geography 2020-2025 (%)
  • Geographic comparison
  • North America - Market size and forecast 2020-2025 ($ million)
  • North America - Year-over-year growth 2020-2025 (%)
  • Europe - Market size and forecast 2020-2025 ($ million)
  • Europe - Year-over-year growth 2020-2025 (%)
  • Asia - Market size and forecast 2020-2025 ($ million)
  • Asia - Year-over-year growth 2020-2025 (%)
  • ROW - Market size and forecast 2020-2025 ($ million)
  • ROW - Year-over-year growth 2020-2025 (%)
  • Key leading countries
  • Market opportunity by geography ($ million)
  • Impact of drivers and challenges
  • Vendor landscape
  • Landscape disruption
  • Industry risks
  • Vendors covered
  • Market positioning of vendors
  • Baxter International Inc. - Overview
  • Baxter International Inc. - Business segments
  • Baxter International Inc. - Key offerings
  • Baxter International Inc. - Key customers
  • Baxter International Inc. - Segment focus
  • Bristol-Myers Squibb Co. - Overview
  • Bristol-Myers Squibb Co. - Product and service
  • Bristol-Myers Squibb Co. - Key offerings
  • Bristol-Myers Squibb Co. - Key customers
  • Bristol-Myers Squibb Co. - Segment focus
  • CSL Ltd. - Overview
  • CSL Ltd. - Business segments
  • CSL Ltd. - Key offerings
  • CSL Ltd. - Key customers
  • CSL Ltd. - Segment focus
  • Grifols SA - Overview
  • Grifols SA - Business segments
  • Grifols SA - Key offerings
  • Grifols SA - Key customers
  • Grifols SA - Segment focus
  • Kedrion Spa - Overview
  • Kedrion Spa - Product and service
  • Kedrion Spa - Key offerings
  • Kedrion Spa - Key customers
  • Kedrion Spa - Segment focus
  • LFB SA - Overview
  • LFB SA - Product and service
  • LFB SA - Key offerings
  • LFB SA - Key customers
  • LFB SA - Segment focus
  • Novartis AG - Overview
  • Novartis AG - Business segments
  • Novartis AG - Key offerings
  • Novartis AG - Key customers
  • Novartis AG - Segment focus
  • Octapharma AG - Overview
  • Octapharma AG - Product and service
  • Octapharma AG - Key offerings
  • Octapharma AG - Key customers
  • Octapharma AG - Segment focus
  • Pfizer Inc. - Overview
  • Pfizer Inc. - Business segments
  • Pfizer Inc. - Key offerings
  • Pfizer Inc. - Key customers
  • Pfizer Inc. - Segment focus
  • Takeda Pharmaceutical Co. Ltd. - Overview
  • Takeda Pharmaceutical Co. Ltd. - Product and service
  • Takeda Pharmaceutical Co. Ltd. - Key offerings
  • Takeda Pharmaceutical Co. Ltd. - Key customers
  • Takeda Pharmaceutical Co. Ltd. - Segment focus
  • Currency conversion rates for US$
  • Research Methodology
  • Validation techniques employed for market sizing
  • Information sources
  • List of abbreviations
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Baxter International Inc.
  • Bristol-Myers Squibb Co.
  • CSL Ltd.
  • Grifols SA
  • Kedrion Spa
  • LFB SA
The following companies as the key players in the global critical care therapeutics market: Baxter International Inc., Bristol-Myers Squibb Co., CSL Ltd., Grifols SA, Kedrion Spa, LFB SA, Novartis AG, Octapharma AG, Pfizer Inc., and Takeda Pharmaceutical Co. Ltd..

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is growing preference for marketed products over alternative treatment options.'

According to the report, one of the major drivers for this market is the high demand for albumin in China.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
  • Baxter International Inc.
  • Bristol-Myers Squibb Co.
  • CSL Ltd.
  • Grifols SA
  • Kedrion Spa
  • LFB SA
  • Novartis AG
  • Octapharma AG
  • Pfizer Inc.
  • Takeda Pharmaceutical Co. Ltd.
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll